SLEEP APNEA ASSOCIATED WITH TICAGRELOR- A PHARMACOVIGILANCE ANALYSIS FROM 2012-2022 FAERS DATABASE

被引:0
|
作者
Hafez, Nada [1 ]
Babayale, Omofolarin [1 ]
Faisaluddin, Mohammed [1 ]
Ahmed, Asmaa [1 ]
机构
[1] Rochester Reg Hosp, Rochester, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1027-11
引用
收藏
页码:1133 / 1133
页数:1
相关论文
共 50 条
  • [1] Ticagrelor and central sleep apnea: analysis of VigiBase, the WHO pharmacovigilance database
    Revol, Bruno
    Jullian-Desayes, Ingrid
    Tamisier, Renaud
    Puel, Vincent
    Mallaret, Michel
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] ADVERSE EVENTS ASSOCIATED WITH SODIUM GLUCOSE CO-TRANSPORTER-2 INHIBITORS: A PHARMACOEPIDEMIOLOGIC ANALYSIS USING FAERS DATABASE 2012-2022
    Gari, M.
    Alrasheed, M.
    Guo, J. J.
    VALUE IN HEALTH, 2023, 26 (06) : S175 - S175
  • [3] Analysis of clinical studies on clozapine from 2012-2022
    Freibuechler, Anton
    Seifert, Roland
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (12) : 9745 - 9765
  • [4] Valproic acid and sleep apnea: A disproportionality signal from the WHO pharmacovigilance database
    Revol, B.
    Jullian-Desayes, I.
    Guichard, K.
    Micoulaud-Franchi, J. A.
    Tamisier, R.
    Philip, P.
    Joyeux-Faure, M.
    Pepin, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 99 - 99
  • [5] Gabapentinoids and Sleep Apnea Syndrome: A Safety Signal from the Who Pharmacovigilance Database
    Pepin, J.
    Revol, B.
    Jullian-Desayes, I.
    Cracowski, J.
    Tamisier, R.
    Mallaret, M.
    Joyeux-Faure, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [6] Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database
    Revol, B.
    Jullian-Desayes, I.
    Cracowski, J. L.
    Tamisier, R.
    Mallaret, M.
    Joyeux-Faure, M.
    Pepin, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 7 - 7
  • [7] Gabapentinoids and sleep apnea syndrome: a safety signal from the WHO pharmacovigilance database
    Revol, Bruno
    Jullian-Desayes, Ingrid
    Cracowski, Jean-Luc
    Tamisier, Renaud
    Mallaret, Michel
    Joyeux-Faure, Marie
    Pepin, Jean-Louis
    SLEEP, 2019, 42 (02)
  • [8] KETAMINE-ASSOCIATED ADVERSE EVENTS: AN ANALYSIS OF THE FAERS DATABASE FROM 2012-2021
    Alamri, K.
    Guo, J. J.
    VALUE IN HEALTH, 2024, 27 (06) : S368 - S368
  • [9] Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022
    Mikaeili, Bahar
    Alqahtani, Zuhair A.
    Hincapie, Ana L.
    Guo, Jeff Jianfei
    CLINICAL RHEUMATOLOGY, 2025, : 1467 - 1474
  • [10] Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database
    Shu, Yamin
    Zhang, Qilin
    He, Xucheng
    Liu, Yanxin
    Wu, Pan
    Chen, Li
    FRONTIERS IN PHARMACOLOGY, 2022, 13